Cargando…
Willingness to pay for a new drug delivery in Parkinson patients
OBJECTIVE: The Swedish reimbursement system operates a system where prices are set based on the expected value to the consumer. This value can be measured using willingness to pay (WTP). AIM: To assess Parkinson’s disease (PD) patients’ WTP for newly developed microtablets of levodopa in combination...
Autores principales: | Lökk, Johan, Olofsson, Sara, Persson, Ulf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199841/ https://www.ncbi.nlm.nih.gov/pubmed/25336962 http://dx.doi.org/10.2147/JMDH.S67929 |
Ejemplares similares
-
Willingness-to-pay to access Ingenol Mebutate Gel for Actinic Keratosis Treatment in the U.S. Setting
por: Willis, Michael, et al.
Publicado: (2014) -
Willingness to pay for osteoporosis risk assessment in primary dental care
por: Christell, Helena, et al.
Publicado: (2019) -
Managing the delivery of venous leg ulcer services: A willingness to pay study
por: Wickramasekera, Nyantara, et al.
Publicado: (2022) -
Are the affluent prepared to pay for the planet? Explaining willingness to pay for public and quasi-private environmental goods in Switzerland
por: Meyer, Reto, et al.
Publicado: (2010) -
Willingness-to-pay for sustainable beer
por: Carley, Sanya, et al.
Publicado: (2018)